양막 시장(2026-2030년)

The global amniotic membrane market is forecasted to grow by USD 3963.1 mn during 2025-2030, accelerating at a CAGR of 16.6% during the forecast period. The report on the global amniotic membrane market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic wounds and associated diseases, expansion of applications in regenerative medicine and surgery, technological advancements and growing body of clinical evidence.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global amniotic membrane market is segmented as below:

By End-User

• Hospitals
• Ambulatory surgical centers
• Specialty clinics
• Research and academic institutes

By Type

• Cryopreserved amniotic membrane
• Dehydrated amniotic membrane

By Product Type

• Single-layer
• Multi-layer

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the shift toward dehydrated and shelf-stable product formulations as one of the prime reasons driving the global amniotic membrane market growth during the next few years. Also, diversification of applications into new medical specialties and development of advanced and combination product formulations will lead to sizable demand in the market.

The report on the global amniotic membrane market covers the following areas:

• Global amniotic membrane market sizing
• Global amniotic membrane market forecast
• Global amniotic membrane market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global amniotic membrane market vendors that include AlloSource, Amnio Technology LLC, Applied Biologics LLC, Corza Ophthalmology, Merakris Therapeutics Inc., MiMedx Group Inc., MTF Biologics, NuVision Biotherapies Ltd, Organogenesis Holdings Inc., Skye Biologics Holdings LLC, Stimlabs LLC, Surgenex LLC, Tides Medical, Ventris Medical LLC, Vivex Biologics Inc., Zimmer Biomet Holdings Inc.. Also, the global amniotic membrane market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Amniotic Membrane Market 2020 - 2024
  • Historic Market Size - Data Table on Global Amniotic Membrane Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.4 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Amniotic Membrane Market
• 6.2 Impact of Geopolitical Conflicts on Global Amniotic Membrane Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Hospitals - Market size and forecast 2025-2030
• 8.4 Ambulatory surgical centers - Market size and forecast 2025-2030
• 8.5 Specialty clinics - Market size and forecast 2025-2030
• 8.6 Research and academic institutes - Market size and forecast 2025-2030
• 8.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Type

• 9.1 Market segments
• 9.2 Comparison by Type
• 9.3 Cryopreserved amniotic membrane - Market size and forecast 2025-2030
• 9.4 Dehydrated amniotic membrane - Market size and forecast 2025-2030
• 9.5 Market opportunity by Type
  • Market opportunity by Type ($ million)

10 Market Segmentation by Product Type

• 10.1 Market segments
• 10.2 Comparison by Product Type
• 10.3 Single-layer - Market size and forecast 2025-2030
• 10.4 Multi-layer - Market size and forecast 2025-2030
• 10.5 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of chronic wounds and associated diseases
  • Expansion of applications in regenerative medicine and surgery
  • Technological advancements and growing body of clinical evidence
• 13.2 Market challenges
  • High cost of treatment and reimbursement uncertainties
  • Stringent regulatory frameworks and ethical considerations
  • Lack of awareness and shortage of skilled professionals
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Shift toward dehydrated and shelf-stable product formulations
  • Diversification of applications into new medical specialties
  • Development of advanced and combination product formulations

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AlloSource
  • AlloSource - Overview
  • AlloSource - Product / Service
  • AlloSource - Key offerings
  • SWOT
• 15.5 Amnio Technology LLC
  • Amnio Technology LLC - Overview
  • Amnio Technology LLC - Product / Service
  • Amnio Technology LLC - Key offerings
  • SWOT
• 15.6 Applied Biologics LLC
  • Applied Biologics LLC - Overview
  • Applied Biologics LLC - Product / Service
  • Applied Biologics LLC - Key offerings
  • SWOT
• 15.7 Corza Ophthalmology
  • Corza Ophthalmology - Overview
  • Corza Ophthalmology - Product / Service
  • Corza Ophthalmology - Key offerings
  • SWOT
• 15.8 Merakris Therapeutics Inc.
  • Merakris Therapeutics Inc. - Overview
  • Merakris Therapeutics Inc. - Product / Service
  • Merakris Therapeutics Inc. - Key offerings
  • SWOT
• 15.9 MiMedx Group Inc.
  • MiMedx Group Inc. - Overview
  • MiMedx Group Inc. - Business segments
  • MiMedx Group Inc. - Key offerings
  • MiMedx Group Inc. - Segment focus
  • SWOT
• 15.10 MTF Biologics
  • MTF Biologics - Overview
  • MTF Biologics - Product / Service
  • MTF Biologics - Key offerings
  • SWOT
• 15.11 NuVision Biotherapies Ltd
  • NuVision Biotherapies Ltd - Overview
  • NuVision Biotherapies Ltd - Product / Service
  • NuVision Biotherapies Ltd - Key offerings
  • SWOT
• 15.12 Organogenesis Holdings Inc.
  • Organogenesis Holdings Inc. - Overview
  • Organogenesis Holdings Inc. - Business segments
  • Organogenesis Holdings Inc. - Key offerings
  • Organogenesis Holdings Inc. - Segment focus
  • SWOT
• 15.13 Stimlabs LLC
  • Stimlabs LLC - Overview
  • Stimlabs LLC - Product / Service
  • Stimlabs LLC - Key offerings
  • SWOT
• 15.14 Surgenex LLC
  • Surgenex LLC - Overview
  • Surgenex LLC - Product / Service
  • Surgenex LLC - Key offerings
  • SWOT
• 15.15 Tides Medical
  • Tides Medical - Overview
  • Tides Medical - Product / Service
  • Tides Medical - Key offerings
  • SWOT
• 15.16 Ventris Medical LLC
  • Ventris Medical LLC - Overview
  • Ventris Medical LLC - Product / Service
  • Ventris Medical LLC - Key offerings
  • SWOT
• 15.17 Vivex Biologics Inc.
  • Vivex Biologics Inc. - Overview
  • Vivex Biologics Inc. - Product / Service
  • Vivex Biologics Inc. - Key offerings
  • SWOT
• 15.18 Zimmer Biomet Holdings Inc.
  • Zimmer Biomet Holdings Inc. - Overview
  • Zimmer Biomet Holdings Inc. - Business segments
  • Zimmer Biomet Holdings Inc. - Key news
  • Zimmer Biomet Holdings Inc. - Key offerings
  • Zimmer Biomet Holdings Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations